Distribution of segmental chromosomal alterations in neuroblastoma
- 18 September 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Clinical and Translational Oncology
- Vol. 23 (6), 1096-1104
- https://doi.org/10.1007/s12094-020-02497-2
Abstract
Background Neuroblastoma (NB) is a heterogeneous tumor with extremely diverse prognosis according to clinical and genetic factors such as specific combinations of chromosomal imbalances. Methods Molecular karyotyping data from a national neuroblastic tumor database of 155 NB samples were analyzed and related to clinical data. Results Segmental chromosomal alterations (SCA) were detected in 102 NB, whereas 45 only displayed numerical alterations. Incidence of SCA was higher in stage M (92%) and MYCN amplified (MNA) NB (96%). Presence of SCA was associated with older age, especially 1q gain and 3p deletion. 96% of the deaths were observed in the SCA group and 85% of the relapsed NB contained SCA. The alteration most commonly associated with a higher number of other segmental rearrangements was 11q deletion, followed by 4p deletion. Whole-chromosome 19 gain was associated with lower stages, absence of SCA and better outcome. Conclusions SCA are not randomly distributed and are concentrated on recurrent chromosomes. The most frequently affected chromosomes identify prognostic factors in specific risk groups. SCA are associated with older age and MNA. We have identified a small subset of patients with better outcome that share whole-chromosome 19 numeric gain, suggesting its use as a prognostic biomarker in NB.Keywords
This publication has 38 references indexed in Scilit:
- Genetic Instability and Intratumoral Heterogeneity in Neuroblastoma with MYCN Amplification Plus 11q DeletionPLOS ONE, 2013
- NeuroblastomaAdvances in Pediatrics, 2011
- Accumulation of Segmental Alterations Determines Progression in NeuroblastomaJournal of Clinical Oncology, 2010
- High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onsetProceedings of the National Academy of Sciences of the United States of America, 2010
- Presence of 1q gain and absence of 7p gain are new predictors of local or metastatic relapse in localized resectable neuroblastomaNeuro-Oncology, 2009
- The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force ReportJournal of Clinical Oncology, 2009
- The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force ReportJournal of Clinical Oncology, 2009
- MYCN gain and MYCN amplification in a stage 4S neuroblastomaCancer Genetics and Cytogenetics, 2003
- Prospective evaluation of the International Neuroblastoma Staging System (INSS) and the International Neuroblastoma Response Criteria (INRC) in a multicentre settingEuropean Journal of Cancer, 1999
- Gain of chromosome arm 17q predicts unfavourable outcome in neuroblastoma patientsEuropean Journal of Cancer, 1997